Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Beyond pharmacy blog

All posts by Gustaf Duhs

Pfizer and Flynn Pharma fined £90m for excessive pricing — what are the implications?

Posted by: Gustaf DuhsFri, 16 Dec 2016

Gustaf Duhs explains the ruling behind the Competition and Markets Authority’s £90m fine on Pfizer and Flynn Pharma’s excessive drug pricing.

Beyond pharmacy blog

Take a look here for thoughts and musings beyond the pharmacy realm

Authors

Tags

Best of the rest 2018, Coronavirus, Ebola 2014, Ebola outbreak 2014, e-cigarettes, Healthy new year, PJ pop 2019, Pre-reg training, sexual health, UK election 2015, Winner 2018, Winner 2020, Writing competition 2018, Writing competition 2020

Blog Archive

Pharmaceutical Journal Blogs

Top Stories

Most Popular

Most Commented

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.